throbber
(19) United States
`(12) Patent Application Publication (10) Pub. No.: US 2012/0245483 A1
`Lundqvist
`(43) Pub. Date:
`Sep. 27, 2012
`
`US 20120245483A1
`
`(54) SYSTEMAND GARMENT FOR MUSCLE
`RELAXATION OF A SPASTIC MUSCLE
`
`(75) Inventor:
`
`Edrik Lundqvist, Stockholm
`
`(73) Assignee:
`
`INERVENTIONS AB, Solna (SE)
`
`(21) Appl. No.:
`
`13/513,223
`
`(22) PCT Filed:
`
`Dec. 2, 2010
`
`PCT/EP2010/068721
`
`(86). PCT No.:
`S371 (c)(1),
`2). (4) Date:
`Jun. 12, 2012
`(2), (4) Date:
`ll. A
`O
`O
`Related U.S. Application Data
`(60) Provisional application No. 61/283.374, filed on Dec.
`3, 2009.
`
`Foreign Application Priority Data
`(30)
`Apr. 27, 2010 (SE) .................................... 1050420-7
`Publication Classification
`
`(51) Int. Cl.
`(2006.01)
`A61N L/36
`(2006.01)
`A6IH I/00
`(2006.01)
`A6IB5/0488
`(52) U.S. Cl. ........................................... 600/546; 601/15
`(57)
`ABSTRACT
`The present invention relates generally to muscle relaxation.
`Muscle relaxation is desired in many disease states, including
`spastic paresis and biomechanical and neuromuscular dys
`function. More specifically, the invention relates to a system
`that causes muscle relaxation by reducing muscular spasticity
`through the stimulation of joints and muscles. The system
`consists of a garment with electrodes, a hardware unit and
`Software controlling the stimulation.
`
`
`
`- 52a
`
`LUMENIS EX1012
`Page 1
`
`

`

`Patent Application Publication
`
`Sep. 27, 2012 Sheet 1 of 13
`
`US 2012/0245483 A1
`
`- N
`
`- 11
`
`r|.
`
`u- 1 1 a
`
`-
`
`- 11b
`
`e
`
`—b-
`
`- - 12
`N--
`
`- 13
`
`Fig. 1
`
`LUMENIS EX1012
`Page 2
`
`

`

`Patent Application Publication
`
`Sep. 27, 2012 Sheet 2 of 13
`
`US 2012/0245483 A1
`
`N u- 11
`
`-Ts
`
`- 1 1 a
`
`--
`
`u-11b
`
`N.
`
`- 14a
`
`-i-
`
`L- 14b
`
`Fig. 2
`
`LUMENIS EX1012
`Page 3
`
`

`

`Patent Application Publication
`
`Sep. 27, 2012 Sheet 3 of 13
`
`US 2012/0245483 A1
`
`
`
`Fig. 3
`
`LUMENIS EX1012
`Page 4
`
`

`

`Patent Application Publication
`
`Sep. 27, 2012 Sheet 4 of 13
`
`US 2012/0245483 A1
`
`30
`
`N
`N A
`
`
`
`Fig. 4
`
`LUMENIS EX1012
`Page 5
`
`

`

`Patent Application Publication
`
`Sep. 27, 2012 Sheet 5 of 13
`
`US 2012/0245483 A1
`
`
`
`Fig. 5
`
`LUMENIS EX1012
`Page 6
`
`

`

`Patent Application Publication
`
`Sep. 27, 2012 Sheet 6 of 13
`
`US 2012/0245483 A1
`
`
`
`Fig. 6
`
`LUMENIS EX1012
`Page 7
`
`

`

`Patent Application Publication
`
`Sep. 27, 2012 Sheet 7 of 13
`
`US 2012/0245483 A1
`
`
`
`LUMENIS EX1012
`Page 8
`
`

`

`Patent Application Publication
`
`Sep. 27, 2012 Sheet 8 of 13
`
`US 2012/0245483 A1
`
`
`
`LUMENIS EX1012
`Page 9
`
`

`

`Patent Application Publication
`
`Sep. 27, 2012 Sheet 9 of 13
`
`US 2012/0245483 A1
`
`
`
`LUMENIS EX1012
`Page 10
`
`

`

`Patent Application Publication
`
`Sep. 27, 2012 Sheet 10 of 13
`
`US 2012/0245483 A1
`
`
`
`s
`
`Visit file/
`VBii
`Yi.
`WBS
`is
`
`
`
`Fig. 10
`
`LUMENIS EX1012
`Page 11
`
`

`

`Patent Application Publication
`
`Sep
`
`27, 2012 Sheet 11 of 13
`
`US 2012/0245483 A1
`
`
`
`LUMENIS EX1012
`Page 12
`
`

`

`Patent Application Publication
`
`Sep. 27, 2012 Sheet 12 of 13
`
`US 2012/0245483 A1
`
`
`
`LUMENIS EX1012
`Page 13
`
`

`

`Patent Application Publication
`
`Sep. 27, 2012 Sheet 13 of 13
`
`US 2012/0245483 A1
`
`
`
`LUMENIS EX1012
`Page 14
`
`

`

`US 2012/0245483 A1
`
`Sep. 27, 2012
`
`SYSTEMAND GARMENT FOR MUSCLE
`RELAXATION OF A SPASTIC MUSCLE
`
`TECHNICAL FIELD
`0001. The present invention relates in general to muscle
`relaxation, and more particular to muscle relaxation for spas
`tic muscles in patients having injuries to the central nervous
`system (CNS) at least by using muscle stimulation.
`
`BACKGROUND
`0002 Injuries to the central nervous system (CNS) are
`difficult to treat and cure. Spastic paresis, which is a patho
`logically increased muscle tonus caused by an injury to the
`central nervous system (CNS) is a significant obstacle for
`prevention of posturing and loss of mobility.
`0003. Today, therapeutic alternatives for the reversal of
`CNS injury symptoms, such as spasticity, are very limited.
`Therapies are constructed to prevent further loss of function,
`rather than alleviating the symptoms. No treatment has been
`found to truly give back function and, in the long run, revers
`ing the injury through muscle relaxation of spastic muscles.
`0004. In addition to the spasms themselves, musculoskel
`etal pain is a common related complaint. Pain originating
`from dysfunction in the musculoskeletal system is in most
`cases caused by muscle spasms due to muscularimbalance. If
`the pain is not treated properly, patients risk developing
`chronic pain syndromes, conditions that are difficult to cure.
`0005. There are several techniques available to affect
`muscles in the human body.
`0006 Electrical muscle stimulation (EMS), also known as
`neuromuscular electrical stimulation or electromyostimula
`tion is a commonly known method for increasing muscle
`mass in specific areas, by providing an electric current into the
`muscle causing contraction, which gradually leads to
`increased mass in the treated muscle. Trancutaneous Electri
`cal Nerve Stimulation (TENS) is closely related to EMS, but
`instead of stimulating muscles to contract, electric stimula
`tion is used to indirectly treat pain, by distracting the brain
`through the stimulation of other body parts. In U.S. Pat. No.
`4.580,572, a garment for electrical monitoring of sites or
`electrical stimulation, such as EMS is disclosed.
`0007. However, none of the currently known muscle
`stimulation techniques is Suited to provide for targeted
`muscle relaxation.
`0008 Hence, a new system, and garment allowing for
`increased muscle relaxation would be advantageous.
`
`SUMMARY OF THE INVENTION
`0009. Accordingly, the present invention preferably seeks
`to mitigate, alleviate or eliminate one or more of the above
`identified deficiencies in the art and disadvantages singly or in
`any combination and solves at least the above mentioned
`problems by providing a system and garment allowing for
`improved muscle relaxation in spastic patients.
`0010. An object of the present invention is to provide for
`muscle relaxation.
`0011
`Furthermore, the invention relates to a system that
`causes muscle relaxation by reducing muscular spasticity
`through the stimulation of several muscles and joints simul
`taneously.
`0012. Furthermore, an object is to reduce muscle spasms
`due to spastic paresis or other dysfunction of the neuromus
`cular system inducing muscle spasms.
`
`0013 Moreover, an object is to reduce posturing and
`development of contractures in patients with spastic paresis.
`0014) Another object is to give spastic patients a self
`Sufficient rehabilitation instrument enabling increased func
`tion and movement leading to better quality of life.
`0015. Another object is to reduce pain in patients with
`spastic paresis and in patients with biomechanical and neu
`romuscular dysfunction.
`0016. Another object is to produce a powerful diagnostic
`tool for therapists specialized in neurology, orthopedics and
`manual therapy.
`0017. Another object is to be a reliable research system in
`neurological research regarding brain injuries.
`0018. Another object is to getting a grading or measuring
`scale for spasticity.
`0019. According to an aspect a system for relaxation of a
`spastic antagonist muscle of a human is provided. The system
`comprises an electronic muscle stimulation device having a
`first electrode and a second electrode for connection to the
`corresponding agonist muscle. The system further comprises
`a vibrator device for connection to a ligament, joint capsule,
`or tendon to which the agonist muscle attaches to the skel
`eton. Moreover, the system comprises control unit configured
`to simultaneously control the electronic muscle stimulation
`device and the vibrator device, by applying a first pulsed
`current signal between the first electrode and the second
`electrode, and a second pulsed current signal to the vibrator
`device.
`0020. According to another aspect a garment comprising
`the system is provided.
`
`BRIEF DESCRIPTION OF THE DRAWINGS
`
`0021. These and other aspects, features and advantages of
`which the invention is capable of will be apparent and eluci
`dated from the following description of embodiments of the
`present invention, reference being made to the accompanying
`drawings, in which
`0022 FIG. 1 illustrates the system according to an
`embodiment;
`0023 FIG. 2 illustrates the system according to another
`embodiment;
`0024 FIG. 3 illustrates a front view of a garment accord
`ing to an embodiment;
`0025 FIG. 4 illustrates a back view of a garment accord
`ing to an embodiment;
`0026 FIG. 5 illustrates a front view of the garment com
`ponents according to an embodiment;
`0027 FIG. 6 illustrates a back view of the garment com
`ponents according to an embodiment;
`0028 FIG. 7 illustrates a front view of EMS/EMG-elec
`trode placement according to an embodiment;
`0029 FIG. 8 illustrates a back view of EMS/EMG-elec
`trode placement according to an embodiment;
`0030 FIG. 9 illustrates a front view of the vibration elec
`trode placement according to an embodiment;
`0031
`FIG. 10 illustrates a back view of the vibration elec
`trode placement according to an embodiment;
`0032 FIG. 11 illustrates a front view of all anatomic elec
`trode placements according to an embodiment;
`0033 FIG. 12 illustrates a back view of all anatomic elec
`trode placements according to an embodiment; and
`
`LUMENIS EX1012
`Page 15
`
`

`

`US 2012/0245483 A1
`
`Sep. 27, 2012
`
`0034 FIG. 13 illustrates a front view of garment compo
`nents, hardware placement, connection ports and cable
`bundle connectors according to an embodiment.
`
`DESCRIPTION OF EMBODIMENTS
`0035. Several embodiments of the present invention will
`be described in more detail below with reference to the
`accompanying drawings in order for those skilled in the art to
`be able to carry out the invention. The invention may, how
`ever, be embodied in many different forms and should not be
`construed as limited to the embodiments set forth herein.
`Rather, these embodiments are provided so that this disclo
`sure will be thorough and complete, and will fully convey the
`scope of the invention to those skilled in the art. The embodi
`ments do not limit the invention, but the invention is only
`limited by the appended patent claims. Furthermore, the ter
`minology used in the description of the particular embodi
`ments illustrated in the accompanying drawings is not
`intended to be limiting of the invention.
`0036 An idea is to combine EMS stimulation and joint
`tissue vibration stimulation for patients with spastic paresis
`and/or musculoskeletal pain in order to achieve improved
`relaxation in the muscle/muscles being spastic.
`0037. The combination of EMS stimulation and joint tis
`Sue vibration stimulation may also be utilized to decrease
`inflammation, decrease muscle tension and building muscles
`to treat imbalance, by utilizing a combination of EMS stimu
`lation for a muscle and vibration stimulation for a joint or
`tendon correlated to the muscle.
`0038. The present inventor has realized that by utilizing
`the generally concept of antagonist muscle pairs, together
`with combination of EMS stimulation and joint tissue stimu
`lation, spastic muscles may be relaxed when the stimulation is
`performed in a certain way. This was done by manual stimu
`lation of patients joint tissues, combined with EMS stimula
`tion. The present inventor has surprisingly found that the
`combination of simultaneous EMS stimulation and joint tis
`Sue vibration gives far better results in terms of relaxation of
`spastic muscles than utilizing EMS stimulation, and vibration
`stimulation, separately. By performing the manual stimula
`tion according to above, a number of specific advantageous
`combinations were found, which is described below.
`0039 Specifically, it was discovered that stimulation may
`have a systemic effect, i.e. that stimulation of a single muscle
`and joint or tendon correlated to the muscle, or a group of
`adjoining muscles and joints or tendons correlated to the
`respective muscles may affect muscles in a different place of
`the body.
`0040 Antagonistic pairs are needed in the body because
`muscles can only exert a pulling force, and can not push
`themselves back into their original positions. An example of
`this kind of muscle pairing is the biceps brachii and triceps
`brachii. When the biceps are contracting, the triceps are
`relaxed, and stretches back to its original position. The oppo
`site happens when the triceps contract.
`0041 Agonist is a classification used to describe a muscle
`that causes specific movement or possibly several movements
`to occur through the process of its own contraction. Each
`antagonist pair comprises an agonist muscle and an antago
`nist muscle. Hence, when the biceps brachii is contracted, it
`acts as the agonist muscle, and the triceps brachii will act as an
`antagonist muscle. On the other hand, when the triceps
`brachii is contracted, it acts as the agonist muscle, and the
`biceps brachii will act as an antagonist muscle.
`
`0042. The present inventor has found that mild agonist
`muscle stimulation leads to reciprocal inhibition of the
`antagonist muscle and slight contraction without shortening
`of the agonist muscle. The joint tissue stimulation facilitates
`the agonist activation and relaxes the antagonist muscle
`through reciprocal inhibition. The concept consists of co
`stimulation of several muscles and joint tissues simulta
`neously to induce muscle relaxation in a group of spastic
`muscles. The idea behind the muscle stimuli is to easily
`stimulate the agonist muscle without shortening it. The ner
`Vous system senses the stimulation, whereby the antagonist
`muscle experiences so called reciprocal inhibition and is pro
`longed due to relaxation, which indirectly leads to a shorten
`ing of the stimulated agonist muscle.
`0043 Prolonged stimulation leads to a general muscle
`relaxation and reduced muscle spasms in the whole body.
`Weak muscles are made stronger which in the long run leads
`to a generalized reduction of muscle spasms and musculosk
`eletal pain; therefore reducing disability and Suffering.
`0044 EMS+Vibration
`0045. In an embodiment, according to FIG. 1, a system 10
`for relaxation of a spastic antagonist muscle of a human is
`provided. The system comprises an electronic muscle stimu
`lation device 11 having a first electrode 11a and a second
`electrode 11b for connection to the corresponding agonist
`muscle. The system 10 further comprises a vibrator device 12
`for connection to a ligament, joint capsule, or tendon to which
`the agonist muscle attaches to the skeleton. Moreover, the
`system comprises a control unit 13 configured to control the
`electronic muscle stimulation device 11 and the vibrator
`device 12, by applying a pulsed EMS current signal between
`the first electrode 11a and the second electrode 11b, and a
`pulsed vibrator current signal to the vibrator device 12.
`0046. Usually, patients having CNS injury symptoms, has
`several spastic muscles, which heavily limits their mobility
`and life quality. According to an embodiment the system
`comprises an electronic muscle stimulation device or a pair of
`first and second electrodes for each agonist of each spastic
`antagonist muscle to be treated, and a vibrator device for each
`corresponding ligament, joint capsule, or tendon to each ago
`nist muscle of each spastic antagonist muscle to be treated.
`0047. In an embodiment, the system comprises a first elec
`trode and second electrode for the majority of the agonist
`muscles in the human body, as well as a vibrator device for
`each of the agonist muscles. The present inventor has realized
`that by utilizing a system providing the majority of the
`antagonist pair muscles in the human body with the EMS
`electrodes, as well as the corresponding joint tissue with
`vibrator devices, even though not all of the majority of
`muscles in the body are spastic, an increased relaxation for
`the truly spastic muscles is achieved, by Stimulation of the
`majority of the muscles. This is believed to be the result of the
`nerve inhibiting signal Substances being released to the Syn
`apses and the cerebrospinal fluid, circulating the brain and
`spinal cord. Therefore other synapses and neurons can be
`affected if in proximity of either the site of release or the
`cerebrospinal fluid. It is e.g. commonly known that decreased
`spasticity in the legs leads to decreased spasticity in the arms.
`The first electrode 11a and/or second electrode 11b may be
`any known EMS electrode suitable for the purpose of muscle
`relaxation, and allowing for reduced discomfort for the
`patient. Each of the first electrode 11a or second electrode
`11b acts as a +/-node and is designed to electrically stimulate
`the muscle to which it is connected.
`
`LUMENIS EX1012
`Page 16
`
`

`

`US 2012/0245483 A1
`
`Sep. 27, 2012
`
`0048. The size of the first 11a and/or second 11b EMS
`electrode is selected based on the muscle to be treated.
`0049. In an embodiment, the first and/or second electrode
`may be directly attached to the skin by means of an adhesive,
`Such as conductive pads or conductive gel.
`0050. The electrodes may e.g. be silicone electrodes, com
`bined with conductive gel. Important properties for elec
`trodes are good skin contact/adhesiveness, good conductivity,
`hypoallergenic properties and durability.
`0051 Pulsed EMS Current Signal
`0052. In general, the parameters of the EMS current signal
`may be chosen which resemble the physiology of the body.
`The signals in the nervous system may be compared to current
`impulses (stimuli) to the synapses. When a certain amount of
`stimuli has occurred, signal Substances are excreted.
`0053 Generally, a phasic EMS-stimulus is given with a
`frequency ranging between 2 and 50 Hz, with a duration
`between 5 to 300 microseconds.
`0054 Muscle relaxation in spastic muscles gives the pos
`sibility to induce controlled functional muscle contraction in
`chosen relaxed muscles. The frequency needed to induce
`muscle contraction is higher than the frequency used for
`optimal antagonist muscle relaxation (20 HZ/30 micros).
`Stimulation frequencies for functional muscle contraction are
`ranging from 25 to 50 Hz, and the duration needed is between
`50-300 microS.
`0055. The pulsed EMS current signal is controlled by at
`least the following parameters; pulse frequency, pulse dura
`tion, pulse strength.
`0056 Experiments have shown that muscles start to con
`tract at a pulse frequency of approximately 15 Hz to approxi
`mately 35 HZ, at which frequency range the central nervous
`system feels the presence of the current signal. The present
`inventor has realized that by choosing a frequency as low as
`possible, but still detectable by the central nervous system,
`the discomfort for the patient is reduced, while the automatic
`relaxation of the spastic antagonist muscle is taken care of by
`the central nervous system. A higher frequency than approxi
`mately 35 Hz would lead to shortening of the stimulated
`agonist muscle and therefore activation of the stretch reflex in
`the antagonist muscle which is not desired, since this would
`lead to a reciprocal spasm of the agonist muscle.
`0057 The pulse duration of the current signal is selected
`Such that it resembles the pulse duration of nervous signals.
`For example, a pulse duration of approximately 5 to 60 micro
`seconds, such as 30 us, has been found to be suitable. How
`ever, even shorter pulse duration could be advantageous. Too
`long pulse duration of the EMS current signal does not cor
`respond to the neurophysiologic parameters of the body. Fur
`thermore, longer pulse duration may also increase the risk of
`muscle shortage, which is not desired.
`0058. In an embodiment, the pulsed EMS current signal
`has a pulse frequency ranging between 10 and 30 Hz with a
`pulse duration ranging between 5 to 60 microseconds.
`0059. According to a preferred embodiment the pulsed
`EMS signal has a pulse frequency of 20 Hz, with pulse dura
`tion of 30 microseconds.
`0060. The EMS current signal strength is selected such
`that it does not exceed the amplitude at which the skin adja
`cent to the first 11a and/or second 11b EMS electrodes starts
`to vibrate. In use, the vibrating, painfree sensation may be felt
`by some patients. Stronger current signals may produce
`muscle shortening and pain in the patient, which is not
`desired. Preferably the current signal strength is selected to lie
`
`in the range of 50% to 75% of the signal strength required to
`feel the vibration in the skin adjacent the first and/or second
`electrode, in use. Hence, the pulsed EMS current signal
`strength does not provide discomfort for the patient, however
`a sparkling ortingling sensation may be felt in some patients.
`
`Vibration Device
`0061. In an embodiment, the vibration device 12 is a micro
`vibration motor, designed to stimulate joint proprioception in
`joint to which is in contact. The vibration device is small,
`round, cylindrical and covered by rubber to enhance friction
`with skin and therefore directing the vibration stimuli to joint
`tissues underlying the skin.
`0062 According to an embodiment the pulsed vibrator
`current signal has a pulse frequency ranging between 5 Hz to
`400 HZ.
`0063 Vibration stimulus is given in three primary fre
`quencies, designated to stimulate three important sensory
`receptors. One frequency is chosen to stimulate Pacinian
`corpuscles, one frequency is chosen to stimulate Merkel’s
`disk receptors and one frequency is chosen to stimulate
`Meissner's corpuscles. The frequency range chosen for
`stimulating Merkel's disk receptors is 5-15 Hz. The fre
`quency for Meissner's corpuscles is ranging between 20-50
`HZ and for Pacinian corpules the stimulation frequency
`ranges between 60-400 Hz. Optimal vibration is defined as
`the mean of these ranges.
`0064 EMG
`0065. In an embodiment according to FIG. 2, the system
`10 further comprises an Electromyography (EMG) device 14
`for evaluating and recording the electrical activity in the
`spastic antagonist muscles.
`0.066
`Based on the electrical activity in the spastic antago
`nist muscle, before and/or during EMS stimulation and vibra
`tion stimulation, the parameters of the EMS current signal or
`vibration current signal may be adapted.
`0067. The EMG device 14 comprises a first EMG elec
`trode 14a and a second EMG electrode 14b for each muscle
`for which the electrical activity is to be monitored.
`0068. The EMG electrode may be of the same type as the
`EMS electrodes 11a, and 11b. Hence, in an embodiment, the
`first 11a, and/or the second 11b electrode of the electronic
`stimulation device, may each act as an EMG electrode for
`together detecting electric signals in the muscle to which they
`are connected.
`0069. In use, the EMG-electrodes 14a, 14b are placed to
`be in contact with the spastic antagonist muscle, whereas the
`EMS electrodes 11a, 11b are to be placed in contact with the
`corresponding agonist muscle.
`0070 Calibration
`0071 Since the spastic muscle behavior in CNS injured
`patients differs greatly, the professional skills of a neuromus
`cular system specialist is required for calibrating the system
`before use. Such that the correctagonist muscles are provided
`with EMS electrodes and joints corresponding thereto are
`provided with vibrator devices. Every chosen muscle stimu
`lation is paired with an anatomically relevant joint stimula
`tion in order to strengthen the desired relaxation effect. Fur
`thermore, the parameters of the pulsed EMS current signal
`need to be selected, which parameters may differ between
`patients.
`0072 According to a non limiting theory of the inventor,
`the current level may need individual adjustment, since some
`muscles lies deeper than others. However, the frequency and
`
`LUMENIS EX1012
`Page 17
`
`

`

`US 2012/0245483 A1
`
`Sep. 27, 2012
`
`pulse duration of the EMS current signal may be more or less
`independent of individual spasticity level, since the nervous
`system does not vary very much between patients.
`0073 Relaxation is initially induced by antagonist muscle
`stimulation by the therapist. The therapist is aided by EMG
`readings showing the relaxation of spastic key muscles. The
`process is called spasticity calibration. The amount of stimuli
`needed (currentxtime, Ixt) gives the amount of energy needed
`to induce reciprocal inhibition of the antagonist muscle. The
`easier the reciprocal inhibition is induced the lower is the
`severity of spasticity. Therefore the therapist can, aided by
`this process, establish the exact amount of stimuli needed for
`every patient.
`0074. During calibration, at least one muscle is chosen for
`spasticity calibration, e.g. based on the readings from the
`EMG device connected to said muscle. The muscle read by
`the EMG device may be the spastic antagonist muscle.
`0075. It is commonly known that spasticity in one muscle,
`may give rise to spasticity in another muscle. Hence, a
`decrease in spasticity in the legs leads to a decrease in spas
`ticity in the arms. Hence, by reading the electrical activity in
`a number of muscles, during calibration, a measure of the
`patient's general muscle spasticity may be obtained (an indi
`cation of mass reflex activity for said patient).
`0076 According to a preferred embodiment applied to the
`whole body, muscles may also be chosen, Such as at least
`three EMG-reading muscles, i.e. three muscles connected to
`the EMG device. For example, one pair of EMG electrodes in
`the arm, one pair of EMG electrodes in the leg and one pair of
`EMG electrodes in the spine or jaw, wherein each pair of
`EMG electrodes are connected to the EMG device. One
`EMG-electrode used for reading of non-muscular electrical
`Surface activity may be placed in a bony area without under
`lying muscle to give a measurement for comparison, used for
`calibration.
`0077. An advantage of this embodiment is that it is pos
`sible to measure the general spasticity and/or general relax
`ation based on EMG readings from only a few of the muscles
`in the patient.
`0078. Another advantage is that the muscles being read by
`the EMG device may be located at some distance from the site
`of the intended EMS stimulated muscles, whereby the leaking
`of current from the EMS electrode to the EMG electrode is
`reduced.
`0079. In an embodiment, calibration may be performed
`during treatment by the system.
`0080 Control Unit
`0081. The control unit comprises a processor for running
`software and a memory onto which the software is stored. The
`control unit may be connected to a power source or a pulse
`generator for generating the pulsed EMS signals, and vibrator
`signals.
`0082. The control unit is portable, and connected with the
`electrodes in the garment and is able to connect to a personal
`computer via e.g. USB or Bluetooth. Different treatment pro
`grams and patterns can be stored in the memory. The control
`unit is configured to run code segments for controlling the
`functionality EMS device 11, vibrator device 12, and option
`ally the EMG device 14 of the system.
`0083. In an embodiment a computer program product is
`provided. The computer program product is stored on a com
`puter-readable medium comprising the Software code
`adapted for controlling the system when executed on a data
`processing apparatus.
`
`I0084 the code segments for controlling the system
`according to some embodiments.
`I0085. In an embodiment the control unit is configured to
`send treatment information to an external device. The treat
`ment information may, e.g. comprise information regarding
`the treatment progress, i.e. improvements in relaxation of the
`muscles. The therapist may receive this information and
`update the treatment strategy, change treatment plan etc.
`I0086. In an embodiment, the control unit is configured to
`receive updated Software from an external device. Such as a
`computer. The updated Software may e.g. be new treatment
`plans, stimulation programs received from the therapist.
`Hence, the system may be updated without the need for a visit
`at the therapist.
`I0087. The external device may comprise software for per
`forming calibration, to control EMS-programs, vibration pro
`grams and EMG-measurements enabling the spasticity cali
`bration mode. Treatment parameters, such as EMS current
`signals, Vibration current signals, treatment time, muscles to
`be treated etc. are utilized in order to create treatment plans.
`The external device Software may comprise a code segment
`for visualizing the system parameters on a display. Hence,
`when therapist selects a stimulation muscle and electrode and
`vibration stimuli placement, this is visualized on the display.
`0088 Treatment Duration
`0089. In an embodiment the treatment duration is one to
`two hours daily, or for a longer duration if the system is only
`used 2 to 4 times a week.
`0090. Garment
`0091. In an embodiment, according to FIGS. 3 and 4, a
`garment 30 comprising the system is provided. Hence, the
`EMS-electrodes, vibrator devices, optional EMG-electrodes
`and the control unit are all included in the garment 30.
`0092. The garment 30 makes it possible for a patient to
`receive treatment wherever he/she is without the need for an
`attending specialist or healthcare personnel. This greatly
`increases the quality of life for the patients and relatives, since
`no trips to the health care clinic are required, as well as the
`patient may retrieve treatment everywhere, as long as the
`garment 30 is worn.
`0093. In an embodiment according to FIGS. 5 and 6, the
`garment 30 comprises seven interlocking parts. One part 51
`for the head and neck; two parts 52a and 52b for elbow,
`forearm and hand; one part 53 for torso, shoulder and upper
`arm; one part 54 for lowerback, lower abdomen, pelvis, thigh,
`hip and upper leg; and finally two parts 55a and 55b for knee,
`lower leg and foot. All parts can be connected to a hardware
`unit 131 separately or in different combinations, these com
`binations ranging from two parts to all seven parts depending
`on the needs of the patient. FIG. 13 illustrates the connection
`points 130 of the parts of the garment.
`0094. It should be appreciated that only a part of the gar
`ment, according to the previous embodiment, may be used,
`depending on the needs of the individual patient. Hence, for
`Some patient there is no need for a full body garment, but one
`or more parts may be sufficient to allow for effective treat
`ment.
`0.095 According to an embodiment, the garment com
`prises of five major textile and Support materials. Elastic
`spandex for areas covering muscles and, embedded in this
`spandex, muscle electrodes for skin contact; firm elastic span
`dex textile in joint areas to induce joint stability and specific
`skin contact of embedded muscle and vibration electrodes;
`and Velcro to interlock the garment parts and also induce joint
`
`LUMENIS EX1012
`Page 18
`
`

`

`US 2012/0245483 A1
`
`Sep. 27, 2012
`
`stability and electrode skin contact. Zippers are placed in the
`different garment parts to enable simple dressing and use of
`the garment. Padding and other supportive materials are
`placed between the textile layers to enhance stability and
`electrode skin contact.
`0096. In order to provide for a perfect garment fit for each
`patient, each garment may be tailor made for each patient.
`Hence, each patient may be individually measured. Based on
`the calibration made by the specialist, the therapist chooses
`which muscles to stimulate and therefore induce muscle
`relaxation of corresponding spastic muscles. The tailor made
`garment is produced and the control unit is programmed with
`the necessary parameters such as to perform a vibrator and
`EMS stimulation in the prescribed manner.
`0097 Based on the individual measurements, a tailor
`made garment may be provided. Sufficient data is sent to a
`factory to ensure tailor made production and delivery of a
`functional garment. Final tailoring (e.g. minor adjustments of
`the garment), calibration and hardware unit programming
`may be performed after construction and delivery of the gar
`ment.
`0098. In another embodiment, the garment may be chosen
`from a big variety of garment component sizes which are
`combined to fit all different possible size requirements.
`0099. The design of the anatomical measurement charts
`enables exact anatomical positioning of electrodes stimulat
`ing specific muscles.
`0100. The type of the first and second electrodes for each
`muscle may be selected based on muscle type, and their
`location in the garment, such as to avoid discomfort for the
`person being treated. Essentially two types of EMS-elec
`trod

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket